Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS)
Xpert bladder cancer monitor in surveillance of bladder cancer: Systematic review and meta-analysis - ScienceDirect
Xpert Bladder Cancer Panel C104 | MMQCI | Maine Molecular Quality Controls
Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer - ScienceDirect
Xpert Bladder Cancer Panel C104 | MMQCI | Maine Molecular Quality Controls
Area under the curve of Xpert® Bladder Cancer Monitor in low-risk,... | Download Scientific Diagram
Xpert Bladder Cancer Monitor for Bladder Cancer Surveillance: First Experiences from a novel mRNA-based Urine Test
Liquid biopsy in bladder cancer: State of the art and future perspectives - ScienceDirect
Verbesserte Onkologiediagnostik
A) Performance of the Xpert Bladder Cancer Monitor to detect all... | Download Scientific Diagram
Xpert® Bladder Cancer Detection - Cepheid - PDF Catalogs | Technical Documentation
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports
Urine tests | Fight Bladder Cancer
![PDF] Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a757ee8a0139076c80a16a1a476318d6fb9daf94/3-Figure1-1.png "PDF] Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma | Semantic Scholar")
PDF] Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma | Semantic Scholar
Verbesserte Onkologiediagnostik
Diagnostic value of Xpert® Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update - Carolina D'Elia, Decio M. Folchini, Christine Mian, Esther Hanspeter, Christine Schwienbacher,
![PDF] Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1348d55e37993bf256c125a861a0a298924b354b/5-Table2-1.png "PDF] Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial. | Semantic Scholar")
PDF] Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial. | Semantic Scholar
Cepheid on X: "Don't miss Dr. Cancel-Tassin's #EAU19 poster presentation on March 17 at 2pm (topic 8.4) about the management of non-muscle invasive # bladdercancer using Cepheid's Xpert Bladder Cancer Monitor test and
The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors
Life | Free Full-Text | Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers
